Overcoming Reduced Glucocorticoid Sensitivity in Airway Disease

[1]  S. Kato,et al.  Retracted: A reduction state potentiates the glucocorticoid response through receptor protein stabilization , 2007, Genes to cells : devoted to molecular & cellular mechanisms.

[2]  F. Martinez,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.

[3]  K. Fong,et al.  Inhaled corticosteroids for stable chronic obstructive pulmonary disease. , 2012, The Cochrane database of systematic reviews.

[4]  L. Wood,et al.  Reduced circulating antioxidant defences are associated with airway hyper-responsiveness, poor control and severe disease pattern in asthma. , 2010, The British journal of nutrition.

[5]  T. Clanton,et al.  Redox modulation of global phosphatase activity and protein phosphorylation in intact skeletal muscle , 2009, The Journal of physiology.

[6]  K. Chung,et al.  Inflammatory biomarkers in airways of patients with severe asthma compared with non‐severe asthma , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[7]  A. Fitzpatrick,et al.  Levels of nitric oxide oxidation products are increased in the epithelial lining fluid of children with persistent asthma. , 2009, The Journal of allergy and clinical immunology.

[8]  Sun Choi,et al.  Oxidative modifications of glyceraldehyde-3-phosphate dehydrogenase play a key role in its multiple cellular functions. , 2009, The Biochemical journal.

[9]  J. Cidlowski,et al.  Emerging roles of glucocorticoid receptor phosphorylation in modulating glucocorticoid hormone action in health and disease , 2009, IUBMB life.

[10]  D. Postma,et al.  Meta-analyses on suspected chronic obstructive pulmonary disease genes: a summary of 20 years' research. , 2009, American journal of respiratory and critical care medicine.

[11]  W. Gong,et al.  Inhibition of NF-kappaB-dependent transcription by MKP-1: transcriptional repression by glucocorticoids occurring via p38 MAPK. , 2009, The Journal of biological chemistry.

[12]  M. Raz,et al.  Effect of N-acetylcysteine on air trapping in COPD: a randomized placebo-controlled study. , 2009, Chest.

[13]  W. Gong,et al.  Inhibition of NF-κB-dependent Transcription by MKP-1 , 2009, The Journal of Biological Chemistry.

[14]  Kazuhiro Ito,et al.  Nitration of distinct tyrosine residues causes inactivation of histone deacetylase 2. , 2009, Biochemical and biophysical research communications.

[15]  M. Drumm,et al.  Loss of CFTR results in reduction of histone deacetylase 2 in airway epithelial cells. , 2009, American journal of physiology. Lung cellular and molecular physiology.

[16]  I. Adcock,et al.  Inhaled corticosteroids as combination therapy with β-adrenergic agonists in airways disease: present and future , 2009, European Journal of Clinical Pharmacology.

[17]  S. Freedman,et al.  Cystic fibrosis , 2009, The Lancet.

[18]  I. Adcock,et al.  Glucocorticoid resistance in inflammatory diseases , 2009, The Lancet.

[19]  Martin J Firth,et al.  Glucocorticoid resistance in T-lineage acute lymphoblastic leukaemia is associated with a proliferative metabolism , 2009, British Journal of Cancer.

[20]  Yan A. Su,et al.  Glucocorticoid receptor (GR) beta has intrinsic, GRalpha-independent transcriptional activity. , 2009, Biochemical and biophysical research communications.

[21]  C. Zhang,et al.  Oral N‐acetylcysteine attenuates pulmonary emphysema and alveolar septal cell apoptosis in smoking‐induced COPD in rats , 2009, Respirology.

[22]  Christopher S. Stevenson,et al.  Inhibition of PI3Kdelta restores glucocorticoid function in smoking-induced airway inflammation in mice. , 2009, American journal of respiratory and critical care medicine.

[23]  K. Chung,et al.  Reversal of Relative Corticosteroid Insensitivity in PBMCs from Patients with COPD by p38 MAPK Inhibition. , 2009, ATS 2009.

[24]  N. Chavannes,et al.  Fluticasone and N-acetylcysteine in primary care patients with COPD or chronic bronchitis. , 2009, Respiratory medicine.

[25]  J. Freyssinet,et al.  Mechanisms of the noxious inflammatory cycle in cystic fibrosis , 2009, Respiratory research.

[26]  K. Gross,et al.  Molecular mechanisms regulating glucocorticoid sensitivity and resistance , 2009, Molecular and Cellular Endocrinology.

[27]  S. Ward,et al.  Mechanisms of chemokine and antigen-dependent T-lymphocyte navigation. , 2009, The Biochemical journal.

[28]  Yan A. Su,et al.  Glucocorticoid receptor (GR) has intrinsic, GRa-independent transcriptional activity , 2009 .

[29]  I. Rahman.  Review: Antioxidant therapeutic advances in COPD , 2008, Therapeutic advances in respiratory disease.

[30]  M. Drumm,et al.  Oxidative stress causes IL8 promoter hyperacetylation in cystic fibrosis airway cell models. , 2009, American journal of respiratory cell and molecular biology.

[31]  Bernhard Kuster,et al.  Oxidative stress modulates theophylline effects on steroid responsiveness. , 2008, Biochemical and biophysical research communications.

[32]  W. Calhoun,et al.  Differential regulation of the transcriptional activity of the glucocorticoid receptor through site-specific phosphorylation , 2008, Biologics : targets & therapy.

[33]  P. Barnes,et al.  The cytokine network in asthma and chronic obstructive pulmonary disease. , 2008, The Journal of clinical investigation.

[34]  M. Konstan.  Ibuprofen therapy for cystic fibrosis lung disease: revisited , 2008, Current opinion in pulmonary medicine.

[35]  K. Gross,et al.  Tissue-specific glucocorticoid action: a family affair , 2008, Trends in Endocrinology & Metabolism.

[36]  J. Collins,et al.  Glycogen Synthase Kinase 3β-Mediated Serine Phosphorylation of the Human Glucocorticoid Receptor Redirects Gene Expression Profiles , 2008, Molecular and Cellular Biology.

[37]  S. Kleeberger,et al.  Oxidants and the pathogenesis of lung diseases. , 2008, The Journal of allergy and clinical immunology.

[38]  Claudio N. Cavasotto,et al.  Glucocorticoid receptor phosphorylation differentially affects target gene expression. , 2008, Molecular endocrinology.

[39]  J. Dayer,et al.  Differential regulation of cytokine production by PI3Kdelta in human monocytes upon acute and chronic inflammatory conditions. , 2008, Molecular immunology.

[40]  K. Selmaj,et al.  Patients with multiple sclerosis resisted to glucocorticoid therapy: abnormal expression of heat-shock protein 90 in glucocorticoid receptor complex , 2008, Multiple sclerosis.

[41]  I. Adcock,et al.  Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction , 2008, European Respiratory Journal.

[42]  I. Adcock,et al.  Relative corticosteroid insensitivity of alveolar macrophages in severe asthma compared with non-severe asthma , 2008, Thorax.

[43]  Rakesh K. Kumar,et al.  Steroid-resistant neutrophilic inflammation in a mouse model of an acute exacerbation of asthma. , 2008, American journal of respiratory cell and molecular biology.

[44]  S. Suissa,et al.  Methodological issues in therapeutic trials of COPD , 2008, European Respiratory Journal.

[45]  J. Haller,et al.  The effects of non-genomic glucocorticoid mechanisms on bodily functions and the central neural system. A critical evaluation of findings , 2008, Frontiers in Neuroendocrinology.

[46]  P. Chakravarty,et al.  Curcumin restores corticosteroid function in monocytes exposed to oxidants by maintaining HDAC2. , 2008, American journal of respiratory cell and molecular biology.

[47]  S. Wenzel,et al.  Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic airways. , 2008, The Journal of allergy and clinical immunology.

[48]  Levels changes of blood leukocytes and intracellular signalling pathways in COPD patients with respect to smoking attitude. , 2008, Clinical biochemistry.

[49]  J. Stamatoyannopoulos,et al.  Interaction of the Glucocorticoid Receptor with the Chromatin Landscape , 2008, Molecular cell.

[50]  S. Medicherla,et al.  p38α-Selective Mitogen-Activated Protein Kinase Inhibitor SD-282 Reduces Inflammation in a Subchronic Model of Tobacco Smoke-Induced Airway Inflammation , 2008, Journal of Pharmacology and Experimental Therapeutics.

[51]  P. Barnes.  Immunology of asthma and chronic obstructive pulmonary disease , 2008, Nature Reviews Immunology.

[52]  L. Fabbri,et al.  Increased activation of p38 MAPK in COPD , 2008, European Respiratory Journal.

[53]  P. J. Barnes,et al.  Global strategy for asthma management and prevention: GINA executive summary , 2008, European Respiratory Journal.

[54]  A. Nicholson,et al.  Different Mitogen-Activated Protein Kinase-Dependent Cytokine Responses in Cells of the Monocyte Lineage , 2008, Journal of Pharmacology and Experimental Therapeutics.

[55]  Bernd Giese,et al.  Targeting phosphoinositide 3-kinase: moving towards therapy. , 2008, Biochimica et biophysica acta.

[56]  S. Kato,et al.  Retraction: A reduction state potentiates the glucocorticoid response through receptor protein stabilization , 2013, Genes to cells : devoted to molecular & cellular mechanisms.

[57]  Richard J Martin,et al.  Airway remodeling and lack of bronchodilator response in steroid-resistant asthma. , 2007, The Journal of allergy and clinical immunology.

[58]  M. Chan-yeung,et al.  Polymorphisms and functional activity in superoxide dismutase and catalase genes in smokers with COPD , 2007, European Respiratory Journal.

[59]  J. Tuckermann,et al.  Glucocorticoid receptor action in beneficial and side effects of steroid therapy: Lessons from conditional knockout mice , 2007, Molecular and Cellular Endocrinology.

[60]  K. Asadullah,et al.  Selective glucocorticoid receptor agonists (SEGRAs): Novel ligands with an improved therapeutic index , 2007, Molecular and Cellular Endocrinology.

[61]  D. Mannino,et al.  Global burden of COPD: risk factors, prevalence, and future trends , 2007, The Lancet.

[62]  S. Denslow,et al.  The human Mi-2/NuRD complex and gene regulation , 2007, Oncogene.

[63]  V. Bours,et al.  Role of IKK and ERK pathways in intrinsic inflammation of cystic fibrosis airways. , 2007, Biochemical pharmacology.

[64]  F. Maltais,et al.  Effect of salmeterol/fluticasone propionate on airway inflammation in COPD: a randomised controlled trial , 2007, Thorax.

[65]  A. Clément,et al.  Enhanced IL-1β-induced IL-8 production in cystic fibrosis lung epithelial cells is dependent of both mitogen-activated protein kinases and NF-κB signaling , 2007 .

[66]  I. Adcock,et al.  Oxidative stress and steroid resistance in asthma and COPD: pharmacological manipulation of HDAC-2 as a therapeutic strategy , 2007, Expert opinion on therapeutic targets.

[67]  P. Barnes.  New molecular targets for the treatment of neutrophilic diseases. , 2007, The Journal of allergy and clinical immunology.

[68]  S. Rennard,et al.  The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease. , 2007, American journal of respiratory and critical care medicine.

[69]  F. Tronche,et al.  Macrophages and neutrophils are the targets for immune suppression by glucocorticoids in contact allergy. , 2007, The Journal of clinical investigation.

[70]  C. Rommel,et al.  PI3Kδ and PI3Kγ: partners in crime in inflammation in rheumatoid arthritis and beyond? , 2007, Nature Reviews Immunology.

[71]  Bing Li,et al.  The Role of Chromatin during Transcription , 2007, Cell.

[72]  Bartolome Celli,et al.  Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. , 2007, The New England journal of medicine.

[73]  D. Curran‐Everett,et al.  Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. , 2007, The Journal of allergy and clinical immunology.

[74]  Andrew H. Miller,et al.  Cytokine-effects on glucocorticoid receptor function: Relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression , 2007, Brain, Behavior, and Immunity.

[75]  J. Collins,et al.  Human Glucocorticoid Receptor β Binds RU-486 and Is TranscriptionallyActive , 2007, Molecular and Cellular Biology.

[76]  T. Lasserson,et al.  Inhaled corticosteroids for stable chronic obstructive pulmonary disease. , 2007, The Cochrane database of systematic reviews.

[77]  J. Cidlowski,et al.  Multiple glucocorticoid receptor isoforms and mechanisms of post-translational modification , 2006, The Journal of Steroid Biochemistry and Molecular Biology.

[78]  A. Nicholson,et al.  Inhibitory effect of p38 mitogen‐activated protein kinase inhibitors on cytokine release from human macrophages , 2006, British journal of pharmacology.

[79]  K. Rogers,et al.  The p110δ Isoform of PI3K Differentially Regulates β1 and β2 Integrin‐Mediated Monocyte Adhesion and Spreading and Modulates Diapedesis , 2006 .

[80]  T. Lawrence,et al.  Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1 , 2006, The Journal of experimental medicine.

[81]  So Ri Kim,et al.  Phosphoinositide 3-kinase-δ inhibitor reduces vascular permeability in a murine model of asthma , 2006 .

[82]  I. Adcock,et al.  Relative corticosteroid insensitivity of peripheral blood mononuclear cells in severe asthma. , 2006, American journal of respiratory and critical care medicine.

[83]  M. Conese,et al.  Dysregulated interleukin-8 secretion and NF-kappaB activity in human cystic fibrosis nasal epithelial cells. , 2006, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[84]  Kazuhiro Ito,et al.  Kinase inhibitors and airway inflammation. , 2006, European journal of pharmacology.

[85]  C. Lemière,et al.  Increased glucocorticoid receptor-beta expression, but not decreased histone deacetylase 2, in severe asthma. , 2006, The Journal of allergy and clinical immunology.

[86]  K. Kurashima,et al.  Asthma severity is associated with an increase in both blood CXCR3+ and CCR4+ T cells , 2006, Respirology.

[87]  Yong Chul Lee,et al.  Inhibition of phosphoinositide 3‐kinase δ attenuates allergic airway inflammation and hyperresponsiveness in murine asthma model , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[88]  G. Gamble,et al.  Functional variants of antioxidant genes in smokers with COPD and in those with normal lung function , 2006, Thorax.

[89]  I. Adcock,et al.  Histone deacetylase 2–mediated deacetylation of the glucocorticoid receptor enables NF-κB suppression , 2006, The Journal of experimental medicine.

[90]  J. Cidlowski,et al.  Antiinflammatory action of glucocorticoids--new mechanisms for old drugs. , 2005, The New England journal of medicine.

[91]  J. Gulcher,et al.  Profiling of genes expressed in peripheral blood mononuclear cells predicts glucocorticoid sensitivity in asthma patients. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[92]  P. Sterk,et al.  Bronchial CD8 cell infiltrate and lung function decline in asthma. , 2005, American journal of respiratory and critical care medicine.

[93]  Malcolm Johnson,et al.  Glucocorticoid receptor nuclear translocation in airway cells after inhaled combination therapy. , 2005, American journal of respiratory and critical care medicine.

[94]  K. Okkenhaug,et al.  Sequential activation of class IB and class IA PI3K is important for the primed respiratory burst of human but not murine neutrophils. , 2005, Blood.

[95]  V. Raia,et al.  Inhibition of p38 mitogen activated protein kinase controls airway inflammation in cystic fibrosis , 2005, Thorax.

[96]  Raj Kumar,et al.  p38 Mitogen-activated protein kinase (MAPK) is a key mediator in glucocorticoid-induced apoptosis of lymphoid cells: correlation between p38 MAPK activation and site-specific phosphorylation of the human glucocorticoid receptor at serine 211. , 2005, Molecular endocrinology.

[97]  Minoru Yoshida,et al.  HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor. , 2005, Molecular cell.

[98]  I. Adcock,et al.  Decreased histone deacetylase activity in chronic obstructive pulmonary disease. , 2005, The New England journal of medicine.

[99]  N. Thomson,et al.  Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma , 2005, Thorax.

[100]  S. Johnston,et al.  Increased interleukin-4, interleukin-5, and interferon-gamma in airway CD4+ and CD8+ T cells in atopic asthma. , 2005, American journal of respiratory and critical care medicine.

[101]  G. Chrousos,et al.  The Human Glucocorticoid Receptor (hGR) β Isoform Suppresses the Transcriptional Activity of hGRα by Interfering with Formation of Active Coactivator Complexes , 2005 .

[102]  N. Thomson,et al.  Asthma and cigarette smoking , 2004, European Respiratory Journal.

[103]  Z. Szatmáry,et al.  Inhibition of Glucocorticoid Receptor-mediated Transcriptional Activation by p38 Mitogen-activated Protein (MAP) Kinase* , 2004, Journal of Biological Chemistry.

[104]  I. Rahman,et al.  Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation, NF-kappaB and pro-inflammatory gene expression. , 2004, Biochemical pharmacology.

[105]  I. Adcock,et al.  Theophylline Restores Histone Deacetylase Activity and Steroid Responses in COPD Macrophages , 2004, The Journal of experimental medicine.

[106]  Irfan Rahman,et al.  Cigarette smoke alters chromatin remodeling and induces proinflammatory genes in rat lungs. , 2004, American journal of respiratory cell and molecular biology.

[107]  J. Mullol,et al.  Expression of glucocorticoid receptors α and β in steroid sensitive and steroid insensitive interstitial lung diseases , 2004, Thorax.

[108]  I. Adcock,et al.  Histone acetylase and deacetylase activity in alveolar macrophages and blood mononocytes in asthma. , 2004, American journal of respiratory and critical care medicine.

[109]  P. Paré,et al.  The nature of small-airway obstruction in chronic obstructive pulmonary disease. , 2004, The New England journal of medicine.

[110]  J. Cidlowski,et al.  The Origin and Functions of Multiple Human Glucocorticoid Receptor Isoforms , 2004, Annals of the New York Academy of Sciences.

[111]  J. Uddin,et al.  Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway , 2004, Nature Immunology.

[112]  K. Oka,et al.  Role of mRNA expression of transcription factors in glucocorticoid sensitivity of peripheral blood mononuclear cells and disease state in rheumatoid arthritis. , 2004, The Journal of rheumatology.

[113]  I. Adcock,et al.  Oxidative stress reduces histone deacetylase 2 activity and enhances IL-8 gene expression: role of tyrosine nitration. , 2004, Biochemical and biophysical research communications.

[114]  M. Regan,et al.  Association of cystic fibrosis with abnormalities in fatty acid metabolism. , 2004, The New England journal of medicine.

[115]  A. Scheffold,et al.  Membrane glucocorticoid receptors (mGCR) are expressed in normal human peripheral blood mononuclear cells and up‐regulated after in vitro stimulation and in patients with rheumatoid arthritis , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[116]  P. Finan,et al.  Essential role for the p110delta phosphoinositide 3-kinase in the allergic response. , 2004, Nature.

[117]  Karl Ekwall,et al.  Sin3: a flexible regulator of global gene expression and genome stability , 2004, Current Genetics.

[118]  M. Galigniana,et al.  Visualization and Mechanism of Assembly of a Glucocorticoid Receptor·Hsp70 Complex That Is Primed for Subsequent Hsp90-dependent Opening of the Steroid Binding Cleft* , 2003, Journal of Biological Chemistry.

[119]  J. Boehm,et al.  p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases , 2003, Nature Reviews Drug Discovery.

[120]  D. Staunton,et al.  Essential Role of Phosphoinositide 3-Kinase δ in Neutrophil Directional Movement , 2003, The Journal of Immunology.

[121]  P. Shah,et al.  Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease. , 2003, American journal of respiratory and critical care medicine.

[122]  A. Morice,et al.  Assessing the burden of respiratory disease in the UK. , 2002, Respiratory medicine.

[123]  J. Mullol,et al.  Expression of glucocorticoid receptor alpha- and beta-isoforms in human cells and tissues. , 2002, American journal of physiology. Cell physiology.

[124]  T. Seemungal,et al.  Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations , 2002, Thorax.

[125]  W. Bailey,et al.  Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution , 2023, Medical science monitor : international medical journal of experimental and clinical research.

[126]  I. Adcock,et al.  A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[127]  K. Resing,et al.  Phosphatase Inhibition Leads to Histone Deacetylases 1 and 2 Phosphorylation and Disruption of Corepressor Interactions* , 2002, The Journal of Biological Chemistry.

[128]  I. Adcock,et al.  p38 Mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma. , 2002, The Journal of allergy and clinical immunology.

[129]  Weidong Wang,et al.  Specific targeting and constitutive association of histone deacetylase complexes during transcriptional repression. , 2002, Genes & development.

[130]  P. Finan,et al.  Phosphoinositide 3-Kinase γ Is an Essential Amplifier of Mast Cell Function , 2002 .

[131]  J. Mullol,et al.  Expression of glucocorticoid receptor alpha- and beta-isoforms in human cells and tissues. , 2002, American journal of physiology. Cell physiology.

[132]  P. Finan,et al.  Phosphoinositide 3-kinase gamma is an essential amplifier of mast cell function. , 2002, Immunity.

[133]  S. Saccani,et al.  p38-dependent marking of inflammatory genes for increased NF-κB recruitment , 2002, Nature Immunology.

[134]  P. Herrlich,et al.  Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor , 2001, The EMBO journal.

[135]  I. Adcock,et al.  Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophages. , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[136]  G. Chrousos,et al.  High Constitutive Glucocorticoid Receptor β in Human Neutrophils Enables Them to Reduce Their Spontaneous Rate of Cell Death in Response to Corticosteroids , 2001, The Journal of experimental medicine.

[137]  J. Bousquet,et al.  Glucocorticoid Receptor α and β in Glucocorticoid Dependent Asthma , 2000 .

[138]  S. Sethi.  Bacterial infection and the pathogenesis of COPD. , 2000, Chest.

[139]  W L Stanford,et al.  Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration. , 2000, Science.

[140]  J. Bousquet,et al.  Glucocorticoid receptor alpha and beta in glucocorticoid dependent asthma. , 2000, American journal of respiratory and critical care medicine.

[141]  R. Eisenman,et al.  Sin Meets NuRD and Other Tails of Repression , 1999, Cell.

[142]  W. Maziak,et al.  Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[143]  K. Chung,et al.  Neutrophilic inflammation in severe persistent asthma. , 1999, American journal of respiratory and critical care medicine.

[144]  C. Haslett,et al.  NF-κB Activation Is a Critical Regulator of Human Granulocyte Apoptosis in Vitro* , 1999, The Journal of Biological Chemistry.

[145]  J. Arends,et al.  Glucocorticoid receptor mRNA levels in bronchial epithelial cells of patients with COPD: influence of glucocorticoids. , 1998, Respiratory medicine.

[146]  M. Garabedian,et al.  Phosphorylation and Inhibition of Rat Glucocorticoid Receptor Transcriptional Activation by Glycogen Synthase Kinase-3 (GSK-3) , 1998, The Journal of Biological Chemistry.

[147]  R. Sakalauskas,et al.  [Comparison of addition of theophylline to inhaled steroid with doubling of the dose of inhaled steroid in asthma]. , 1998, Pneumologie.

[148]  K. Chung,et al.  A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma. , 1997, The New England journal of medicine.

[149]  K. Yamamoto,et al.  Mitogen-activated and cyclin-dependent protein kinases selectively and differentially modulate transcriptional enhancement by the glucocorticoid receptor , 1997, Molecular and cellular biology.

[150]  W. Pratt,et al.  Steroid receptor interactions with heat shock protein and immunophilin chaperones. , 1997, Endocrine reviews.

[151]  P. Barnes,et al.  Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. , 1997, American journal of respiratory and critical care medicine.

[152]  J. M. Cousin,et al.  Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. , 1996, Journal of immunology.

[153]  Joseph A. DiDonato,et al.  Immunosuppression by Glucocorticoids: Inhibition of NF-κB Activity Through Induction of IκB Synthesis , 1995, Science.

[154]  J. Cidlowski,et al.  Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors , 1995, Molecular and cellular biology.

[155]  W. Busse.  Corticosteroid resistance in asthma: a clinical hurdle and mystery , 1990, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[156]  E. Langhoff,et al.  Methylprednisolone Resistance of Cystic Fibrosis Lymphocytes , 1984, Pediatric Research.

[157]  G. Crompton,et al.  Corticosteroid resistance in chronic asthma. , 1981 .

[158]  A. Mirsky,et al.  Structural Modifications of Histones and their Possible Role in the Regulation of RNA Synthesis. , 1964, Science.